Literature DB >> 20831505

Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients.

Stephanie E Combs1, Malte Ellerbrock, Thomas Haberer, Daniel Habermehl, Angelika Hoess, Oliver Jäkel, Alexandra Jensen, Swantje Klemm, Marc Münter, Jakob Naumann, Anna Nikoghosyan, Susanne Oertel, Katia Parodi, Stefan Rieken, Jürgen Debus.   

Abstract

UNLABELLED: The Heidelberg Ion Therapy Center (HIT) started clinical operation in November 2009. In this report we present the first 80 patients treated with proton and carbon ion radiotherapy and describe patient selection, treatment planning and daily treatment for different indications. PATIENTS AND METHODS: Between November 15, 2009 and April 15, 2010, 80 patients were treated at the Heidelberg Ion Therapy Center (HIT) with carbon ion and proton radiotherapy. Main treated indications consisted of skull base chordoma (n = 9) and chondrosarcoma (n = 18), malignant salivary gland tumors (n=29), chordomas of the sacrum (n = 5), low grade glioma (n=3), primary and recurrent malignant astrocytoma and glioblastoma (n=7) and well as osteosarcoma (n = 3). Of these patients, four pediatric patients aged under 18 years were treated.
RESULTS: All patients were treated using the intensity-modulated rasterscanning technique. Seventy six patients were treated with carbon ions (95%), and four patients were treated with protons. In all patients x-ray imaging was performed prior to each fraction. Treatment concepts were based on the initial experiences with carbon ion therapy at the Gesellschaft für Schwerionenforschung (GSI) including carbon-only treatments and carbon-boost treatments with photon-IMRT. The average time per fraction in the treatment room per patient was 29 minutes; for irradiation only, the mean time including all patients was 16 minutes. Position verification was performed prior to every treatment fraction with orthogonal x-ray imaging.
CONCLUSION: Particle therapy could be included successfully into the clinical routine at the Department of Radiation Oncology in Heidelberg. Numerous clinical trials will subsequently be initiated to precisely define the role of proton and carbon ion radiotherapy in radiation oncology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831505     DOI: 10.3109/0284186X.2010.498432

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  23 in total

Review 1.  [Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer].

Authors:  S E Combs; D Habermehl; J Werner; M W Büchler; J Debus
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

Review 2.  Carbon ion radiotherapy in the treatment of gliomas: a review.

Authors:  Timothy D Malouff; Jennifer L Peterson; Anita Mahajan; Daniel M Trifiletti
Journal:  J Neurooncol       Date:  2019-09-30       Impact factor: 4.130

3.  Lauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective?

Authors:  Eleanor A Blakely
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

4.  The role of image-guided intensity modulated proton therapy in glioma.

Authors:  David R Grosshans; Radhe Mohan; Vinai Gondi; Helen A Shih; Anita Mahajan; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

5.  Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework.

Authors:  Kerstin A Kessel; Nina Bougatf; Christian Bohn; Daniel Habermehl; Dieter Oetzel; Rolf Bendl; Uwe Engelmann; Roberto Orecchia; Piero Fossati; Richard Pötter; Manjit Dosanjh; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-07-24       Impact factor: 3.481

6.  In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.

Authors:  Takamitsu A Kato; Akihisa Tsuda; Mitsuru Uesaka; Akira Fujimori; Tadashi Kamada; Hirohiko Tsujii; Ryuichi Okayasu
Journal:  Radiat Oncol       Date:  2011-09-14       Impact factor: 3.481

7.  Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.

Authors:  Stefan Rieken; Daniel Habermehl; Thomas Haberer; Oliver Jaekel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-21       Impact factor: 3.481

8.  Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.

Authors:  Daniel Habermehl; Katrin Henkner; Swantje Ecker; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

9.  Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro.

Authors:  Hiroshi Fujisawa; Paula C Genik; Hisashi Kitamura; Akira Fujimori; Mitsuru Uesaka; Takamitsu A Kato
Journal:  Radiat Oncol       Date:  2013-04-15       Impact factor: 3.481

10.  Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.

Authors:  Stephanie E Combs; Kerstin A Kessel; Klaus Herfarth; Alexandra Jensen; Susanne Oertel; Claudia Blattmann; Swantje Ecker; Angelika Hoess; Eike Martin; Olaf Witt; Oliver Jäkel; Andreas E Kulozik; Jürgen Debus
Journal:  Radiat Oncol       Date:  2012-10-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.